#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes Endpoints NewsNew drug combination shows significant weight loss in obesity and type 2 diabetes trial Irish Independent‘Godzilla’ of weight-loss drugs could provide other important health benefits The GuardianEli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC‘Astonishing’ fat jab combination causes record weight loss The Telegraph
